A new oral fluid monitoring test for patients on chronic opioids could improve therapy adherence, patient safety and help physicians to better identify drug diversion, developers Cordant Health Solutions announced.
The Cordant Comprehensive Oral fluid Rx Evaluation (CORE) test compares a patient’s oral fluid prescription pain medication levels with an expected drug steady-state range consistent with the prescribed dosage regimen.
“With CORE, providers get similar benefits to blood
MARCH 30, 2017